🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
31/08/1981 0,0172 USD
01/06/1981 0,0172 USD
02/03/1981 0,0172 USD
02/12/1980 0,0172 USD
29/08/1980 0,0152 USD
02/06/1980 0,0152 USD
28/02/1980 0,0152 USD
03/12/1979 0,0152 USD
31/08/1979 0,0126 USD
25/05/1979 0,0126 USD
01/03/1979 0,0126 USD
04/12/1978 0,0126 USD
28/08/1978 0,0113 USD
26/05/1978 0,0113 USD
02/03/1978 0,0113 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/05/2020 73,47 73,59 71,98 72,14 -1,97% 2,19% 12.602.410
06/05/2020 74,76 75,04 73,55 73,59 -1,14% 1,99% 12.414.922
05/05/2020 73,71 75,19 73,25 74,44 +1,50% 2,63% 7.401.395
04/05/2020 74,45 74,46 72,73 73,34 -1,04% 2,32% 8.850.255
01/05/2020 75,25 75,25 73,41 74,11 -2,10% 2,45% 9.518.565
30/04/2020 76,16 76,72 75,52 75,71 -1,77% 1,58% 11.638.878
29/04/2020 78,43 78,43 75,41 77,07 -0,51% 3,84% 13.687.194
28/04/2020 77,46 78,46 76,50 77,46 -3,33% 2,54% 20.273.560
27/04/2020 77,51 80,79 77,13 80,13 +3,13% 4,73% 12.786.753
24/04/2020 77,86 78,34 77,31 77,70 +0,68% 1,32% 7.686.451
23/04/2020 76,52 78,13 76,50 77,18 +1,13% 2,13% 8.152.497
22/04/2020 75,57 76,96 75,22 76,32 +1,81% 2,30% 11.933.890
21/04/2020 77,88 78,53 74,63 74,96 -5,46% 5,01% 17.876.574
20/04/2020 79,03 80,28 77,06 79,29 -0,43% 4,07% 11.675.768
17/04/2020 80,11 80,31 78,66 79,64 +0,55% 2,05% 15.433.162
16/04/2020 78,86 79,51 78,49 79,20 +1,13% 1,29% 9.145.058
15/04/2020 77,51 79,16 76,87 78,31 -0,93% 2,95% 10.809.072
14/04/2020 78,56 79,39 77,03 79,05 +2,86% 3,00% 12.155.333
13/04/2020 78,07 78,69 76,17 76,85 -2,36% 3,23% 7.706.678
09/04/2020 77,45 79,48 76,51 78,71 +1,07% 3,83% 13.876.568
08/04/2020 75,55 79,20 74,75 77,88 +3,90% 5,89% 11.481.888
07/04/2020 77,94 78,22 74,81 74,96 -2,18% 4,37% 10.657.950
06/04/2020 74,74 77,15 74,33 76,63 +5,32% 3,77% 14.314.108
03/04/2020 72,79 73,89 71,87 72,76 -0,81% 2,78% 10.039.211
02/04/2020 72,50 73,59 70,64 73,35 +4,16% 4,07% 12.843.345
01/04/2020 71,24 72,01 69,65 70,42 -4,08% 3,32% 11.665.288
31/03/2020 72,76 74,05 72,06 73,42 -0,01% 2,73% 15.079.672
30/03/2020 70,25 74,04 69,54 73,43 +7,28% 6,40% 15.803.316
27/03/2020 68,51 70,07 67,99 68,44 -2,45% 3,04% 12.467.218
26/03/2020 65,02 70,78 64,98 70,16 +7,78% 8,92% 18.052.848